前不久,中国大陆某药企生产的中成药银翘解毒片因被检出含有西药成分扑热息痛,被港方勒令召回。香港卫生署的发言人表示,在港销售的中成药不应含有西药成分。随后的调查结果显示,系因该药品生产企业生产的银翘解毒片与精制银翘解毒片(该药品为中西药复方制剂,批准的处方中含有扑热息痛60mg/片)共用同一组压片机,清场不彻底导致的产品的交叉污染。而在中国内地,中西药复方制剂也一直广受争议。 Not long ago, a medicine manufacturer in mainland China, Yinyaojiedu, a proprietary Chinese medicine, was ordered to recall by the Hong Kong side for being detected with paracetamol, a western medicine ingredient. A spokesman for Hong Kong’s Department of Health said proprietary Chinese medicines sold in Hong Kong should not contain western medicines. Subsequent survey results showed that the same group of tablets was shared by Yinqiaojiedu tablets and refined Yinqiaojiedu tablets produced by the drug manufacturer (the drug was formulated in Chinese and Western medicines and the prescription was approved to contain paracetamol 60mg / tablet) Clean-up does not completely lead to cross-contamination of the product. In mainland China, Chinese and Western medicine compound has also been widely controversial.